Table 1

Clinical, laboratory and MR spectroscopy data for neuromyelitis optica (NMO) patients and controls

NMO patientsControl groupp Values
n=24n=12
Sex (women/men)17/78/40.95
Age in years (mean±SD)44.6±10.731.1±6.90.01
Disease duration, y (mean±SD)6.1±5.5
No of relapses (mean±SD)4±2.3
NMO-IgG antibody positive17/24 (58.6%)
NAWM
NAA/creatinine (mean±SD)1.89±0.261.91±0.150.8
Choline/creatinine (mean±SD)1.03±0.181.08±0.140.7
NAGM
NAA/creatinine (mean±SD)1.62±0.211.59±0.180.8
Choline/creatinine (mean±SD)0.89±0.20.94±0.20.7
Myo-inositol (mean±SD)0.42±0.120.42±0.180.9
  • NAA, N-acetyl aspartate; NAGM, normal-appearing grey matter; NAWM, normal-appearing white matter.